🌐 The company covers the entire development process for the biotech industry.
🏢 The facility will focus on upstream processing, downstream processing, manufacturing, and analytical services.
💼 This expansion reflects the ongoing growth and demand in the biopharmaceutical industry.
🌱 WuXi Bio’s Massachusetts facility will contribute to the development of new drugs and therapies.
Introduction:
The article discusses the expansion of WuXi Biologics’ facility in Massachusetts, which will create 200 new jobs and enhance the company’s contract development and manufacturing capabilities in the US.
- WuXi Biologics is expanding its facility in Massachusetts to meet the growing demand for biologics development and manufacturing.
- The expansion will add 200 new jobs to the facility and enhance WuXi Biologics’ capacity to support its global clients.
- The facility will focus on contract development and manufacturing services for biologics, including cell line development, process development, and clinical and commercial manufacturing.
- WuXi Biologics aims to accelerate the development and commercialization of biologics for its clients by providing integrated and efficient services.
- The expansion highlights the company’s commitment to the US market and its contribution to the growth of the biotechnology industry in Massachusetts.
Conclusion:
WuXi Biologics’ expansion of its Massachusetts facility will boost its capacity to provide contract development and manufacturing services for biologics. The addition of 200 jobs will contribute to the growth of the biotechnology sector in Massachusetts. With its integrated services and commitment to advancing biologics development, WuXi Biologics is well-positioned to meet the increasing demand in the global biotechnology industry.